Navigation Links
The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market
Date:10/27/2010

EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two syndicated Nephrology TreatmentTrends® publications (TreatmentTrends®: US Nephrology Q310 and TreatmentTrends®: Renal Dietitians 2010). These reports provide information gleaned from on-line surveys with 200 nephrologists and 205 renal dietitians and capture insight into attitudes, perceptions and self-reported prescribing behavior with a focus on renal anemia and bone and mineral metabolism in chronic kidney disease and dialysis.  

In the renal anemia market, use of erythropoietin stimulating agents (ESAs) in patients with chronic kidney disease, not on dialysis (CKD-ND) is showing signs of stabilization. Although use is still far lower than it was just a few years ago, for the first time in almost a year, the percent of Stage 4 CKD-ND patients on ESAs is trending up instead of down. While not a statistically significant change, use of Centocor Ortho-Biotech's Procrit is lower than in prior quarters, and monthly contact rates for Procrit representatives are significantly lower than last year and than monthly contact rates for Amgen's Aranesp. Procrit also seems to be losing a competitive advantage on a number of attributes it once "owned". Despite prior projections of increased use of intravenous (IV) iron, use has remained steady as have the percent of nephrologists who report stocking and administering IV iron in their office. Use of the newest IV iron agent, AMAG's Feraheme, is showing signs of a plateau; for the third quarter in a row, Feraheme share has remained relatively flat among IV iron treated CKD-ND patients. Moreover, the percent of nephrologists reporting use of Feraheme has not changed.

There have been some major changes in the bone and mineral metabolism market, particularly as it relates to parathyroid hormone (PTH) modifiers. The majority of both nephrologists and renal dietitians are aware that DaVita, one of
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
5. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
6. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
7. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
8. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
9. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
10. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
11. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... report, "Amaranth Seed Oil Market by Extraction type (SFE, ... (Cosmetic & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & ... published by MarketsandMarkets, defines and segments the Amaranth ... of the market size in terms of value. ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... 2011 Fukuda Denshi USA has announced the introduction ... United States. The color portable ultrasound unit provides outstanding ... for diagnostic use in numerous specialty markets. ... technologies to improve diagnostic confidence," said Ray Usukura, President ...
... Particle Sciences Inc. (PSI), a leading pharmaceutical ... of sterilizing medical devices.  The patent covers the notion ... the medical device.  Free radicals are, of course, an ... catheter coated with a free radical generating particle would, ...
Cached Medicine Technology:Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. 2Particle Sciences Granted Patent on Self Sterilizing Medical Devices 2
(Date:8/29/2014)... 2014 - Despite US Preventive Services Task Force recommendations ... several of which may be ameliorated through technological approaches ... Langone Medical Center published online August 21, 2014 in ... JGIM ). , David Levine, MD, MA, a third ... NYU Langone, and colleagues found that compared to usual ...
(Date:8/29/2014)... August 29, 2014 According to ... begin accepting applications next month for medical marijuana, ... into accepting marijuana as a legalized medicine. New ... will be permitted to operate in accordance with ... be best suited to handle legal cannabis. ...
(Date:8/29/2014)... The microbiology testing sector is one of ... it is also the hugest challenge facing suppliers during ... spread of AIDS – still the world’s key health ... of opportunistic infections (OIs); bioterrorism threat; advancements in technologies ... medicines. Although for certain infections the etiology remains a ...
(Date:8/29/2014)... Floors of hospitals and other medical facilities ... many patients are relegated to lying down or sitting ... etc. Two inventors from Perrysburg, Ohio, have designed the ... This special pair of socks helps prevent slips and ... are relegated to beds or chairs from standing and ...
(Date:8/29/2014)... The 8th Annual Paint Columbus Pink® is a series of ... Contest, Light of Life Ceremony, Power in Prayer, Bright Pink ... all in support of cancer awareness. , Paint Columbus Pink ... Pink Foam and Obstacle Challenge on Saturday, October 4th, 2014 ... Georgia 31904. It will be the first foam and obstacle ...
Breaking Medicine News(10 mins):Health News:Options for weight loss your primary care doctor might not know about 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2
... AMA Makes ,House Call, to Washington, Discusses New National Physician ... ... The American Medical,Association (AMA) National House Call campaign visits Washington today to,draw ... Medicare patients. Medicare plans to slash physician payments,10 percent on January 1, ...
... N.Y., Sept. 18 Lynn Clark,Callister, R.N., Ph.D., ... has joined the March of Dimes National Nurse ... nursing leaders who,give direction and counsel to March ... Dimes Nurse Advisory Council members represent the finest,maternal-child ...
... Insight Now(TM) automatically imports data from health plans, labs, ... ... health care actions, EATONTOWN, ... provider, has developed an on-line personal health,record with a built-in ...
... Sept. 18 ,The HealthCentral Network, Inc. ( ... today announced a collaboration leveraging,APF,s strength as ... with HealthCentral.com,s multimedia capabilities and extensive,online community ... officially,kicked off today with the posting of ...
... Suite operates with Gryphon compliance services ... in increased productivity for call centers, OKLAHOMA ... of,intelligent customer interaction solutions, today announced that it ... worldwide leader in,On-Demand Contact Governance solutions. This agreement ...
... Demand Entertainment Package for a ... Marks First LodgeNet Deployment in a Children,s Hospital, ... Corporation (Nasdaq: LNET ) and Children,s Hospital,of Pittsburgh ... "kid,friendly" LodgeNetRX Interactive Patient Television System, the company,s,first ever ...
Cached Medicine News:Health News:Medicare Cuts to Physicians Will Harm Washington Seniors 2Health News:Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council 2Health News:Triveris Introduces Personal Health Record with Built-in Health Advisor 2Health News:The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain 2Health News:The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain 3Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 2Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 3Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 2Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 3
EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
... developed to detect the presence of ... The information is clinically useful in ... - a3 chain antibody formation along ... primary diagnostic parameters. Since there are ...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
...
Medicine Products: